• 1
    Call TG, Noel P, Habermann TM, Beard CM, O'Fallon WM, Kurland LT. Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1994;69:315-322.
  • 2
    Call TG, Phyliky RL, Noel P, et al. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc. 1994;69:323-328.
  • 3
    Kyle RA, Nobrega FT, Kurland LT, Elveback LR. The 30-year trend of leukemia in Olmsted County, Minnesota, 1935 through 1964. Mayo Clin Proc. 1968;43:342-353.
  • 4
    Linos A, Kyle RA, Elveback LR, Kurland LT. Leukemia in Olmsted County, Minnesota, 1965-1974. Mayo Clin Proc. 1978;53:714-718.
  • 5
    Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575-583.
  • 6
    Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635-639.
  • 7
    Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512-520.
  • 8
    Fazi C, Scarfo L, Pecciarini L, et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood. 2011;118:6618-6625.
  • 9
    Scarfo L, Fazi C, Ghia P. MBL versus CLL: how important is the distinction? Hematol Oncol Clin North Am. 2013;27:251-265.
  • 10
    Shanafelt TD, Kay NE, Rabe KG, et al. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population. Leukemia. 2012;26:373-376.
  • 11
    Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
  • 12
    Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446-5456.
  • 13
    Shanafelt TD, Kay NE, Rabe KG, et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol. 2009;27:3959-3963.
  • 14
    Shanafelt TD, Kay NE, Call TG, et al. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5×109 L−1 but a B-cell lymphocyte count <5×109 L−1? Leuk Res. 2008;32:1458-1461.
  • 15
    Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113:4188-4196.
  • 16
    Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87:1202-1213.
  • 17
    St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011; 1731059-1068.
  • 18
    Shanafelt TD, Rabe KG, Kay NE, et al. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Cancer. 2010;116:4777-4787.
  • 19
    Moonshadow Mobile, Inc. Population of Olmsted County, Minnesota: Census 2010 and 2000 Interactive Map, Demographics, Statistics, Graphs, Quick Facts. Eugene, OR: Moonshadow Mobile, Inc.; 2012. Available at: Accessed September 23, 2013.
  • 20
    Molica S, Mauro FR, Giannarelli D, et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica. 2011;96:277-283.
  • 21
    Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010: Chronic Lymphocytic Leukemia. Bethesda, MD: National Cancer Institute; 2013. Available at: Accessed July 26, 2013.
  • 22
    Seftel MD, Demers AA, Banerji V, et al. High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. Leuk Res. 2009;33:1463-1468.
  • 23
    Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001;92:1325-1330.
  • 24
    Moreira J, Rabe KG, Cerhan JR, et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia. 2013;27:136-141.
  • 25
    Solomon B, Rabe KG, Moreira J, et al. Risk of cancer in patients with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed patients compared to controls [abstract]. Blood (ASH Annual Meeting Abstracts). 2012;120. Abstract 2893.